Your browser doesn't support javascript.
loading
Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna, Zuzana; Miskovska, Vera; Roska, Jan; Jurkovicova, Dana; Pulzova, Lucia Borszekova; Sestakova, Zuzana; Hurbanova, Lenka; Machalekova, Katarina; Chovanec, Michal; Rejlekova, Katarina; Svetlovska, Daniela; Kalavska, Katarina; Kajo, Karol; Babal, Pavel; Mardiak, Jozef; Ward, Thomas A; Mego, Michal; Chovanec, Miroslav.
Afiliação
  • Cierna Z; Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Miskovska V; 1st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Roska J; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Jurkovicova D; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Pulzova LB; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Sestakova Z; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Hurbanova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Machalekova K; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Chovanec M; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Svetlovska D; National Cancer Institute, Bratislava, Slovakia.
  • Kalavska K; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Kajo K; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Babal P; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Mardiak J; Translational Research Unit, Comenius University, Bratislava, Slovakia.
  • Ward TA; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Mego M; Translational Research Unit, Comenius University, Bratislava, Slovakia.
  • Chovanec M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
BMC Cancer ; 20(1): 17, 2020 Jan 06.
Article em En | MEDLINE | ID: mdl-31906898
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Cisplatino / Neoplasias Embrionárias de Células Germinativas / Reparo do DNA / Proteína de Xeroderma Pigmentoso Grupo A / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Eslováquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Cisplatino / Neoplasias Embrionárias de Células Germinativas / Reparo do DNA / Proteína de Xeroderma Pigmentoso Grupo A / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Eslováquia